BACKGROUND: Adjuvant acupuncture for the symptomatic treatment of migraine reduces the frequency of headaches and may be at least similarly effective to treatment with prophylactic drugs. METHODS: This article describes an open-label randomized controlled clinical trial with two groups: the intervention group (n=42) and the waiting-list control group (n=44). This study occurred at the Czech-Chinese Center for Traditional Chinese Medicine at the University Hospital Hradec Kralove between October 2015 and April 2017. RESULTS: After 12 weeks of acupuncture, the number of migraine days was reduced by 5.5 and 2.0 days in the acupuncture and the waiting-list control groups, respectively, with a statistically significant inter-group difference of 2.0 migraine days (95% CI: -4 to -1). A significantly greater reduction in the number of migraine days per 4 weeks was reached at the end of the 6-month follow-up period in the acupuncture vs. control groups (Δ -4.0; 95% CI: -6 to -2). A statistically significant difference was observed in the number of responders to treatment (response defined as at least a 50% reduction in average monthly migraine day frequency) in the acupuncture vs waiting-list control groups (50% vs 27%; p<0.05) at the end of the intervention. A significantly greater percentage of responders to treatment was noted in the intervention vs control groups at the 6-month follow-up (81% vs 36%; p<0.001). CONCLUSION: Acupuncture can reduce symptoms and medication use, both short term and long term, as an adjuvant treatment in migraine prophylaxis in Czech patients.

Czech Chinese Center for Traditional Chinese Medicine University Hospital Hradec Kralove Hradec Kralove Czech Republic

Department of Neurology University Hospital Hradec Kralove Hradec Kralove Czech Republic

Faculty of Pharmacy in Hradec Kralove Charles University Hradec Kralove Czech Republic

Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine Shanghai People's Republic of China

Zobrazit více v PubMed

Natoli JL, Manack A, Dean B, et al. Global prevalence of chronic migraine: a systematic review. Cephalalgia. 2010;30(5):599–609. PubMed

GBD 2016 Disease and Injury Incidence and Prevalence Collaborators Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390(10100):1211–1259. PubMed PMC

Buse DC, Lipton RB. Global perspectives on the burden of episodic and chronic migraine. Cephalalgia. 2013;33:885–890. PubMed

Lipton RB, Silberstein SD, Saper JR, Bigal ME, Goadsby PJ. Why headache treatment fails. Neurology. 2003;60(7):1064–1070. PubMed

Wells RE, Bertisch SM, Buettner C, Phillips RS, McCarthy EP. Complementary and alternative medicine use among adults with migraines/severe headaches. Headache. 2011;51(7):1087–1097. PubMed PMC

Adams J, Barbery G, Lui CW. Complementary and alternative medicine use for headache and migraine: a critical review of the literature. Headache. 2013;53(3):459–473. PubMed

Rhee TG, Harris IM. Gender differences in the use of complementary and alternative medicine and their association with moderate mental distress in U.S. adults with migraines/severe headaches. Headache. 2017;57(1):97–108. PubMed

Lee J, Bhowmick A, Wachholtz A. Does complementary and alternative medicine (CAM) use reduce negative life impact of headaches for chronic migraineurs? A national survey. Springerplus. 2016;5:1006. PubMed PMC

Schiapparelli P, Allais G, Castagnoli Gabellari I, Rolando S, Terzi MG, Benedetto C. Non-pharmacological approach to migraine prophylaxis: part II. Neurol Sci. 2010;31:S137–S139. PubMed

Mauskop A. Nonmedication, alternative, and complementary treatments for migraine. Continuum (Minneap Minn) 2012;18(4):796–806. PubMed

Linde K, Allais G, Brinkhaus B, et al. Acupuncture for the prevention of episodic migraine. Cochrane Database Syst Rev. 2016;6:CD001218. PubMed PMC

White A. A cumulative review of the range and incidence of significant adverse events associated with acupuncture. Acupunct Med. 2004;22:122–133. PubMed

Witt CM, Pach D, Brinkhaus B, et al. Safety of acupuncture: results of a prospective observational study with 229,230 patients and introduction of a medical information and consent form. Forsch Komplementmed. 2009;16:91–97. PubMed

Frass M, Strassl RP, Friehs H, Müllner M, Kundi M, Kaye AD. Use and acceptance of complementary and alternative medicine among the general population and medical personnel: a systematic review. Ochsner J. 2012;12:45–56. PubMed PMC

Pokladnikova J, Selke-Krulichova I. Prevalence of complementary and alternative medicine use in the general population in the Czech Republic. Forsch Komplementmed. 2016;23(1):22–28. PubMed

University Hospital Hradec Kralove [webpage on the Internet] Czech-Chinese Centre of Traditional Chinese Medicine. 2017. [Accessed February 5, 2017]. Available from: https://www.fnhk.cz/tcm.

Czech Medical Acupuncture Society of the Czech Medical Association of J. E. Purkyně [webpage on the Internet] Akupunktura a přidružené techniky. 2017. [Accessed February 5, 2017]. Available from: http://www.akupunktura.cz/cs/akupunktura-a-pridruzene-techniky.

Headache Classification Subcommittee of the International Headache Society (HIS) The international classification of headache disorders 3rd edition. Cephalalgia. 2013;33(9):629–808. PubMed

Wang Y, Xue CC, Helme R, et al. Acupuncture for frequent migraine: a randomized, patient/assessor blinded, controlled trial with one-year follow-up. Evid Based Complement Alternat Med. 2015;2015:14. PubMed PMC

World Health Organization . Standard Acupuncture Nomenclature. Manila, Philippines: World Health Organization; 1993.

Wuxi Jiajian Medical Instrument Co. Ltd [webpage on the Internet] Acupuncture Rational (22–24) 2017. [Accessed February 14, 2017]. Available from: http://jiaji-anchina.en.made-in-china.com/

Linde K, Allais G, Brinkhaus B, et al. Acupuncture for migraine prophylaxis. Cochrane Database Syst Rev. 2009;1:CD001218. PubMed PMC

Vincent C, Lewith G. Placebo controls for acupuncture studies. J R Soc Med. 1995;88:199–202. PubMed PMC

Langevin HM, Wayne PM, MacPherson H, et al. Paradoxes in acupuncture research: strategies for moving forward. Evid Based Complement Alternat Med. 2011;2011:180805. PubMed PMC

Collins SL, Moore RA, McQuay HJ. The visual analogue pain intensity scale: what is moderate pain in millimetres? Pain. 1997;72(1–2):95–97. PubMed

WHO Collaborating Centre for Drug Statistics Methodology [webpage on the Internet] ATC/DDD Index 2017. 2017. [Accessed February 7, 2017]. Available from: https://www.whocc.no/atc_ddd_index/

Tfelt-Hansen P, Block G, Dahlöf C, et al. Guidelines for controlled trials of drugs in migraine: second edition. Cephalalgia. 2000;20(9):765–786. PubMed

Stewart WF, Lipton RB, Dowson AJ, Sawyer J. Development and testing of the migraine disability assessment (MIDAS) questionnaire to assess headache-related disability. Neurology. 2001;56(6 suppl 1):S20–S28. PubMed

MacPherson H, Altman DG, Hammerschlag R, et al. Revised Standards for reporting interventions in clinical trials of acupuncture (STRICTA): extending the CONSORT statement. PLoS Med. 2010;7:E1000261. PubMed PMC

Consort [webpage on the Internet] Transparent Reporting of Trials. 2017. [Accessed June 15, 2017]. Available from: http://www.consort-statement.org/

Faul F, Erdfelder E, Lang AG, Buchner A. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods. 2007;39(2):175–191. PubMed

Diener HC, Matias-Guiu J, Hartung E, et al. Efficacy and tolerability in migraine prophylaxis of flunarizine in reduced doses: a comparison with propranolol 160 mg daily. Cephalalgia. 2002;22:209–221. PubMed

Brandes JL, Saper JR, Diamond M, et al. Topiramate for migraine prevention: a randomized controlled trial. JAMA. 2004;291:965–973. PubMed

Silberstein SD. Preventive migraine treatment. Continuum (Minneap Minn). Review. Headache. 2015;21(4 Headache):973–989. PubMed PMC

Silberstein SD, Neto W, Schmitt J, Jacobs D, MIGR-001 Study Group Topiramate in migraine prevention: results of a large controlled trial. Arch Neurol. 2004;61(4):490–495. PubMed

Klapper J. Divalproex sodium in migraine prophylaxis: a dose- controlled study. Cephalalgia. 1997;17(2):103–108. PubMed

Gray RN, Goslin RE, McCrory DC, Eberlein K, Tulsky J, Hasselblad V. Drug Treatments for the Prevention of Migraine Headache. Agency for Health Care Policy and Research; Rockville, MD: 1999. (Technical Reviews No 2.3). PubMed

Linde K, Streng A, Jürgens S, et al. Acupuncture for patients with migraine: a randomized controlled trial. JAMA. 2005;293(17):2118–2125. PubMed

Facco E, Liguori A, Petti F, et al. Traditional acupuncture in migraine: a controlled, randomized study. Headache. 2008;48(3):398–407. PubMed

Economic analysis of acupuncture for migraine prophylaxis